T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript

Page 2 of 2

John Sperzel: John Sprague, do you want to take that?

John Sprague: Yes. So Ben, we ended the year – well, go back to Q3 because that’s what we’ve disclosed and the share count hasn’t changed much since then. But we had at – the Q3, suffer with me for a second.

Ben Haynor: Sure.

John Sprague: It should be about $4.5 million.

Ben Haynor: Okay. So basically, just the small amount of ATM sales and the conversion is the way to think about it.

John Sprague: Yes, correct.

Ben Haynor: Okay. Great. Well, that’s all I had for now, gentlemen. Thanks for taking the questions.

John Sprague: Thank you, Ben.

John Sperzel: Thank you.

Operator: Thank you. There are no further questions in the queue. I will now hand the conference back to John Sperzel, Chairman and CEO, for closing remarks. Please go ahead.

John Sperzel: I’d like to thank you all for joining our Q4 2023 and full year 2023 earnings call. We look forward to updating you as we progress through 2024. Thank you, and have a good night.

Operator: Thank you, everyone. This concludes today’s event. You may disconnect at this time, and have a wonderful day. Thank you for your participation.

Follow T2 Biosystems Inc. (NASDAQ:TTOO)

Page 2 of 2